Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127855821 | 12785582 | 1 | I | 2015 | 20160920 | 20160927 | 20160927 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201609007709 | ELI LILLY AND CO | 67.00 | YR | M | Y | 0.00000 | 20160926 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127855821 | 12785582 | 1 | PS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | UNK UNK, UNKNOWN | U | U | 21462 | INJECTION | |||||||
| 127855821 | 12785582 | 2 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | UNK, UNKNOWN | U | U | 21462 | INJECTION | |||||||
| 127855821 | 12785582 | 3 | SS | CARBOPLATINE | CARBOPLATIN | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 127855821 | 12785582 | 4 | SS | CARBOPLATINE | CARBOPLATIN | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 127855821 | 12785582 | 5 | C | SKENAN | MORPHINE SULFATE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 127855821 | 12785582 | 6 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 127855821 | 12785582 | 7 | C | LYRICA | PREGABALIN | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 127855821 | 12785582 | 8 | C | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | UNK, UNKNOWN | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127855821 | 12785582 | 1 | Lung neoplasm malignant |
| 127855821 | 12785582 | 3 | Lung neoplasm malignant |
| 127855821 | 12785582 | 5 | Product used for unknown indication |
| 127855821 | 12785582 | 6 | Product used for unknown indication |
| 127855821 | 12785582 | 7 | Product used for unknown indication |
| 127855821 | 12785582 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127855821 | 12785582 | HO |
| 127855821 | 12785582 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127855821 | 12785582 | Asthenia | |
| 127855821 | 12785582 | Hypotension | |
| 127855821 | 12785582 | Hypothermia | |
| 127855821 | 12785582 | Malignant neoplasm progression | |
| 127855821 | 12785582 | Off label use | |
| 127855821 | 12785582 | Pulmonary arterial hypertension | |
| 127855821 | 12785582 | Right ventricular failure | |
| 127855821 | 12785582 | Shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127855821 | 12785582 | 1 | 2015 | 0 | ||
| 127855821 | 12785582 | 2 | 2016 | 0 | ||
| 127855821 | 12785582 | 3 | 2015 | 0 | ||
| 127855821 | 12785582 | 4 | 2016 | 0 |